Page 8 - Stemcell Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

B.C.’s ‘world-class’ biotech sector plays key role in developing COVID-19 treatments and vaccines B.C.'s biotech is punching above its weight, with key vaccine developments and helping develop treatments to ease the suffering of those infected Author of the article: Gordon Hoekstra Publishing date: May 08, 2021  •  3 hours ago  •  12 minute read  •  The COVID-19 mRNA vaccine from Pfizer-BioNTech used technology developed in B.C. by Acuitas Therapetuics. The green half-sphere is a cutaway view of the lipid nanoparticle, 1/1000th the wi...

B.C.’s ‘world-class’ biotech sector plays key role in developing COVID-19 treatments and vaccines B.C.'s biotech is punching above its weight, with key vaccine developments and helping develop treatments to ease the suffering of those infected Author of the article: Gordon Hoekstra Publishing date: May 07, 2021  •  May 12, 2021  •  12 minute read  •  The COVID-19 mRNA vaccine from Pfizer-BioNTech used technology developed in B.C. by Acuitas Therapetuics. The green half-sphere is a cutaway view of the lipid nanoparticle, 1/1000th the widt...

Global Primary Cells Market Size Worth US$ 1.7 Bn By 2025, Growing At A CAGR Of 10.8% iCrowd Newswire 06 May 2021, 05:47 GMT+10 Primary cells are booming on account of the escalating demand for monoclonal antibodies and the growing focus on personalized medicine. Primary cells are separated from human or animal tissue via enzymatic or mechanical methods. This cell is placed in an artificial environment in glass or plastic containers for support with a specialized medium containing essential nutrients and growth factors to support proliferation. The primary cell also provides a model system fo...

Rising Demand For Tissue Engineering And Organ Transplantation Will Boost The Organoids And Spheroids Market, Forecast To Touch US$ 1.8 Bn By 2027 At A CAGR Of 19.8% iCrowd Newswire The organoids and spheroids market are growing at a steady pace on account of the innovation in the tissue culture system and frequent failures in organ transplantation surgeries, and the technological developments in the 3D spheroid technology. The growth of the organoids and spheroids market is further driven by the surging demand for organoid-based research models in the developed regions and the increased app...

Abstract Duchenne muscular dystrophy (DMD) is a fatal muscle disease caused by the lack of dystrophin, which maintains muscle membrane integrity. We used an adenine base editor (ABE) to modify splice donor sites of the dystrophin gene, causing skipping of a common DMD deletion mutation of exon 51 (∆Ex51) in cardiomyocytes derived from human induced pluripotent stem cells, restoring dystrophin expression. Prime editing was also capable of reframing the dystrophin open reading frame in these cardiomyocytes. Intramuscular injection of ∆Ex51 mice with adeno-associated virus serotype-9 encodin...